ATG5 and Guillain-Barre syndrome: However, the immunoblot analysis demonstrated that the protein levels of autophagy markers LC3-II, ATG5, beclin-1, SQSTM1, and NBR1 did not significantly differ between the PBMCs of GBS patients and healthy controls (Figure 2b).